vs
Side-by-side financial comparison of Incyte (INCY) and OLD REPUBLIC INTERNATIONAL CORP (ORI). Click either name above to swap in a different company.
OLD REPUBLIC INTERNATIONAL CORP is the larger business by last-quarter revenue ($2.4B vs $1.3B, roughly 1.9× Incyte). Incyte runs the higher net margin — 23.8% vs 13.8%, a 10.1% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (19.8% vs 6.7%). Over the past eight quarters, OLD REPUBLIC INTERNATIONAL CORP's revenue compounded faster (13.2% CAGR vs 10.4%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Old Republic International Corporation is an American property insurance and title insurance company. The company is headquartered in Chicago, Illinois.
INCY vs ORI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.4B |
| Net Profit | $303.3M | $330.0M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | — |
| Net Margin | 23.8% | 13.8% |
| Revenue YoY | 19.8% | 6.7% |
| Net Profit YoY | 91.7% | 34.7% |
| EPS (diluted) | $1.47 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $2.4B | ||
| Q4 25 | $1.5B | $2.4B | ||
| Q3 25 | $1.4B | $2.4B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.1B | $2.1B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.1B | $2.3B | ||
| Q2 24 | $1.0B | $1.9B |
| Q1 26 | $303.3M | $330.0M | ||
| Q4 25 | $299.3M | $206.5M | ||
| Q3 25 | $424.2M | $279.5M | ||
| Q2 25 | $405.0M | $204.4M | ||
| Q1 25 | $158.2M | $245.0M | ||
| Q4 24 | $201.2M | $105.3M | ||
| Q3 24 | $106.5M | $338.9M | ||
| Q2 24 | $-444.6M | $91.8M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | — | ||
| Q3 25 | 32.5% | 14.6% | ||
| Q2 25 | 43.6% | 11.8% | ||
| Q1 25 | 19.5% | 14.6% | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 12.8% | 18.2% | ||
| Q2 24 | -45.8% | 6.1% |
| Q1 26 | 23.8% | 13.8% | ||
| Q4 25 | 19.9% | 8.6% | ||
| Q3 25 | 31.1% | 11.5% | ||
| Q2 25 | 33.3% | 9.3% | ||
| Q1 25 | 15.0% | 11.6% | ||
| Q4 24 | 17.1% | 5.3% | ||
| Q3 24 | 9.4% | 14.5% | ||
| Q2 24 | -42.6% | 4.9% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $0.82 | ||
| Q3 25 | $2.11 | $1.11 | ||
| Q2 25 | $2.04 | $0.81 | ||
| Q1 25 | $0.80 | $0.98 | ||
| Q4 24 | $0.90 | $0.42 | ||
| Q3 24 | $0.54 | $1.32 | ||
| Q2 24 | $-2.04 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $5.9M |
| Total Assets | $7.3B | $29.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $987.3M | — |
| Q1 26 | $5.6B | $5.9M | ||
| Q4 25 | $5.2B | $5.9B | ||
| Q3 25 | $4.7B | $6.4B | ||
| Q2 25 | $4.2B | $6.2B | ||
| Q1 25 | $3.7B | $5.9B | ||
| Q4 24 | $3.4B | $5.6B | ||
| Q3 24 | $3.2B | $6.4B | ||
| Q2 24 | $3.0B | $6.0B |
| Q1 26 | $7.3B | $29.6M | ||
| Q4 25 | $7.0B | $29.9B | ||
| Q3 25 | $6.3B | $30.3B | ||
| Q2 25 | $5.8B | $29.3B | ||
| Q1 25 | $5.7B | $28.0B | ||
| Q4 24 | $5.4B | $27.8B | ||
| Q3 24 | $5.0B | $28.8B | ||
| Q2 24 | $4.7B | $27.5B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INCY
Segment breakdown not available.
ORI
| operating | $2.2B | 92% |
| Other | $201.8M | 8% |
